Status:
NOT_YET_RECRUITING
Online Pivotal Response Treatment Training in Autism Spectrum Disorder
Lead Sponsor:
Stanford University
Conditions:
Autism Spectrum Disorder
Autism
Eligibility:
All Genders
2-5 years
Phase:
NA
Brief Summary
This is a research study that will assess the effects of a Pivotal Response Treatment Online Training Course (PRT-O) for training parents of children with Autism Spectrum Disorder (ASD). The study wil...
Eligibility Criteria
Inclusion
- 2:0 to 5:11 years at the time of consent,
- diagnosed with ASD (based on history, review of available medical records including diagnostic testing, e.g., Autism Diagnostic Observation Schedule) or suspicion of Autism Spectrum Disorder diagnosis, and confirmed with Autism Diagnostic Interview-Revised (ADI-R),
- with significant adaptive communication deficits (i.e., either a Vineland-3 Communication subscale 2 Standard Deviations below average for 2 and 3 year olds and 3 Standard Deviations below for 4 and 5 year olds or a Vineland-3 Expressive V-scale Score 2 Standard Deviations below average for 2 and 3 year olds, or 3 Standard Deviations below for 4 and 5 year old, and at least moderate severity on the Clinical Global Impressions Severity (CGI-S) language subscale),
- an English-speaking parent able to consistently participate in study procedures and conduct treatment in English,
- stable psychotropic medication(s) or biomedical intervention(s) for at least 1 month prior to baseline measurements with no anticipated changes during study participation,
- stable treatment (ABA, Floortime, or other interventions), speech therapy, and school placement for at least 1 month prior to baseline measurements with no expected changes during study participation,
- no more than 60 minutes of 1:1 speech therapy per week
Exclusion
- Children who have a primary language other than English
- parent or child diagnosed with severe psychiatric disorder or unstable medical problem
- previous adequate trial of pivotal response treatment resulting in parent meeting Pivotal Response Treatment fidelity of implementation at baseline
- Receiving more than 15 hours of in home 1:1 ABA per week
Key Trial Info
Start Date :
December 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2028
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT06523387
Start Date
December 1 2025
End Date
December 30 2028
Last Update
September 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University
Stanford, California, United States, 94305-5719